These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25200866)

  • 1. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
    Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
    World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
    Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.
    Khan O; Patsouras D; Ravindraanandan M; Abrar MM; Schizas A; George M; Malde S; Thurairaja R; Khan MS; Sahai A
    Eur Urol Focus; 2021 May; 7(3):638-643. PubMed ID: 32622667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
    Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
    Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
    Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
    Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pelvic exenteration for late complications of radiation-induced pelvic injury: a preliminary study].
    He YJ; Zhou ZL; Qin QY; Huang BJ; Huang XY; Li JM; Zhu MM; Yao B; Wang DJ; Qiu JG; Wang H; Ma TH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):940-946. PubMed ID: 37849264
    [No Abstract]   [Full Text] [Related]  

  • 9. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
    Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
    World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
    Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
    Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
    J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
    Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
    Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
    Berek JS; Howe C; Lagasse LD; Hacker NF
    Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
    Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
    Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?
    Backes FJ; Tierney BJ; Eisenhauer EL; Bahnson RR; Cohn DE; Fowler JM
    Gynecol Oncol; 2013 Jan; 128(1):60-64. PubMed ID: 22892363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration: surgical aspects and analysis of early and late morbidity in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):273-81. PubMed ID: 22191127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US.
    Vigneswaran HT; Schwarzman LS; Madueke IC; David SM; Nordenstam J; Moreira D; Abern MR
    Ann Surg Oncol; 2021 May; 28(5):2790-2800. PubMed ID: 33105501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
    Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
    Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.